Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Gross Profit (2020 - 2025)

iSpecimen has reported Gross Profit over the past 6 years, most recently at -$690744.0 for Q4 2025.

  • Quarterly results put Gross Profit at -$690744.0 for Q4 2025, down 446.69% from a year ago — trailing twelve months through Dec 2025 was $376378.0 (down 92.96% YoY), and the annual figure for FY2025 was $24110.0, down 99.42%.
  • Gross Profit for Q4 2025 was -$690744.0 at iSpecimen, down from -$98001.0 in the prior quarter.
  • Over the last five years, Gross Profit for ISPC hit a ceiling of $4.2 million in Q4 2021 and a floor of -$690744.0 in Q4 2025.
  • Median Gross Profit over the past 5 years was $1.5 million (2022), compared with a mean of $1.4 million.
  • Biggest five-year swings in Gross Profit: surged 175.06% in 2024 and later plummeted 446.69% in 2025.
  • iSpecimen's Gross Profit stood at $4.2 million in 2021, then crashed by 82.3% to $735197.0 in 2022, then surged by 56.14% to $1.1 million in 2023, then plummeted by 82.64% to $199241.0 in 2024, then plummeted by 446.69% to -$690744.0 in 2025.
  • The last three reported values for Gross Profit were -$690744.0 (Q4 2025), -$98001.0 (Q3 2025), and $454753.0 (Q2 2025) per Business Quant data.